Canlyniadau Chwilio - Textor, Stephen C

“Current Approaches to Renovascular Hypertension” gan Textor, Stephen C.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Attending Rounds: A Patient with Accelerated Hypertension and an Atrophic Kidney gan Textor, Stephen C.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

“Renovascular Hypertension: Is there still a role for stent revascularization? ” Current Opinion in Nephrology and Hypertension gan Textor, Stephen C.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

“Renal Arterial Disease and Hypertension” gan Textor, Stephen C.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Medically Complex Living Kidney Donors: Where Are We Now? gan Textor, Stephen C.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

What Price For Blood Pressure Control? gan Textor, Stephen C.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

State of the Art: Renovascular Hypertension and Ischemic Nephropathy gan Textor, Stephen C., Lerman, Lilach

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Does Renal Artery Stenting Prevent Clinical Events? gan Textor, Stephen C., Misra, Sanjay

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Inflammatory Cell Markers as Indicators of Atherosclerotic Renovascular Disease gan Textor, Stephen C., Lerman, Lilach O.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Diagnostic criteria for renovascular disease: where are we now? gan Herrmann, Sandra M.S., Textor, Stephen C.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Gained in translation: Protective paradigms for the post-stenotic kidney gan Lerman, Lilach O., Textor, Stephen C.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Paradigm Shifts in Atherosclerotic Renovascular Disease: Where Are We Now? gan Textor, Stephen C., Lerman, Lilach O.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Hypertension in 2015: Treatment of resistant hypertension: Impact and evolving treatment options gan Lerman, Lilach O., Textor, Stephen C.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

BP Targets in CKD, Mortality, and SPRINT: What Have We Learned? gan Textor, Stephen C., Schwartz, Gary L.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Evidence and Renovascular Disease: Trials and Mistrials? gan Textor, Stephen C., Herrmann, Sandra M.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Current Concepts in the Treatment of Renovascular Hypertension gan Herrmann, Sandra M, Textor, Stephen C

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Rediscovering Renovascular Hypertension gan Textor, Stephen C., Taler, Sandra J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Renovascular Hypertension gan Herrmann, Sandra M, Textor, Stephen C

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Invited Review: “Percutaneous revascularization for ischemic nephropathy: Past, Present and Future” gan Textor, Stephen C., Misra, Sanjay, Oderich, Gustavo

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Renal Artery Stenosis: If and when to intervene gan Textor, Stephen C., McKusick, Michael M.

Cael y testun llawn Cael y testun llawn Cael y testun llawn